- ACVIM Forum
- Continuing Education
- Resources For...
- Grants & Awards
- News & Publications
- About ACVIM
One of the revised hallmarks of cancer is dysregulated energy metabolism. This session will cover the historical and modern concepts of glucose utilization and energy generation in cancer, how it may affect tumor cell behavior, and strategies for intervention.The cancer stem cell theory states that tumor growth is driven by a small number of dedicated cancer stem cells (CSCs). These cells are endowed with the ability to self-renew (leading to unlimited cell division and maintenance of the stem cell pool), differentiate into non-CSCs and are intrinsically resistant to conventional therapeutics. This theory explains the clinical observations of almost inevitable tumor relapse after initially successful chemo and/or radiotherapy, and metastasis. This module reviews the biology of CSCs and provides insights into CSC plasticity, interaction with the niche, tumor repopulation and clinical implications of therapeutic response.
RACE Application Status
This module has been submitted and approved for 1.25 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval.
For additional questions, please contact us at Learning@ACVIM.org.
David Argyle is a graduate of Veterinary Medicine and Surgery from the University of Glasgow. He gained his PhD in Immunology and Oncology from the same department. He has served as a clinical academic for the Universities of Glasgow, Wisconsin-Madison and Edinburgh. He has served as Chair of Clinical Studies and as Postgraduate Dean for the College of Medicine and Veterinary Medicine. In 2011 he was appointed William Dick chair of Veterinary Clinical Studies and Dean of Veterinary Medicine at The Royal (Dick) School of Veterinary Studies. He is also Deputy Head of College for The College of Medicine and Veterinary Medicine. He is chair of the examination board for the ECVIM sub-specialty in Oncology. He is an RCVS and European recognized specialist in veterinary oncology, his major interests are cancer biology and comparative oncology. He was elected FRSE and FRCVS in 2016 for meritorious contributions to knowledge. He was elected FRSA in 2019 for contributions to social progress and development.
Dr. Pang completed her PhD in cancer cell signalling at the CRUK Cancer Research Centre and during her PhD she identified a novel p21 feedback loop in the regulation of p53. Dr. Pang subsequently worked at KuDOS Pharmaceuticals in Cambridge developing novel small molecule inhibitors against members of the phosphoinositide 3-kinase related kinase family, with the aim of sensitising cancer cells to DNA damage. Currently, Dr. Pang is a research fellow at The Roslin Institute and a member of The Comparative Oncology and Stem Cell Research Group at the University of Edinburgh. She teaches cell biology to graduate entry veterinary students and is a course organiser of the MSc Animal Biosciences course. The focus of Dr. Pang’s research is on unravelling the biology of cancer stem cells and further understanding the molecular mechanisms driving tumour repopulation after therapy.
ACVIM Diplomates and candidates: $0
ECEIM, ECVIM-CA and ECVN Diplomates and candidates: $30
On demand courses are hosted in ACVIM’s online learning system ACVIM Online, powered by VetBloom.
Individual access has been provided to enrolled participants via email or log in using your ACVIM.org username and password. You will be taken to your Learner Dashboard where any course you are enrolled in will show in the Current Learning section.
All ACVIM Oncology Diplomates and candidates have been automatically enrolled in each Science of Veterinary
The ACVIM has developed nine (9) Science of Veterinary Oncology (SOVO) online courses that are currently available and complimentary for ACVIM members with five (5) more in development and coming soon. These modules offer foundational building blocks of core knowledge areas pertaining to veterinary oncology and were developed based on the Job Task Analysis review performed in 2016. All modules are led by industry experts and each module is RACE-approved.